Gracias Antonio J.'s Form 4 filing
Harmony Biosciences Holdings, Inc. (HRMY) · filed Nov 5, 2024
- Accession no.
- 0001213900-24-094654
- Filed
- Nov 5, 2024, 5:48 PM ET
- Trade date
- Nov 1-5, 2024
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $139.4M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gracias Antonio J.CIK 0001495158 | Director, 10% Owner |
| Sabater Juan A.CIK 0001821210 | Director, 10% Owner |
| Valor Equity Partners IV L.P.CIK 0001705506 | 10% Owner |
| Valor Equity Partners IV-B L.P.CIK 0001705512 | 10% Owner |
| Valor Equity Partners IV-A L.P.CIK 0001705542 | 10% Owner |
| Valor IV Pharma Holdings, LLCCIK 0001821186 | 10% Owner |
| Valor Equity Capital IV LLCCIK 0001821936 | 10% Owner |
| Valor Equity Associates IV L.P.CIK 0001822427 | 10% Owner |
| Valor Management L.P.CIK 0001822428 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Nov 1, 2024 | Common Stock | SSaleDisposed | −4,000,000 | $30.30 | −$121,210,000 | 7,218,033 | Direct | |
| Nov 5, 2024 | Common Stock | SSaleDisposed | −600,000 | $30.30 | −$18,181,500 | 6,618,033 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.
Remarks
Valor IV Pharma Holdings, LLC is the holder of record of the shares reported herein. Valor Funds Group LLC is the general partner of Valor Management L.P., which is the managing member of Valor Equity Capital IV LLC, which is the general partner of Valor Equity Associates IV L.P., which, in turn, is the general partner of limited partnerships (Valor Equity Partners IV L.P, Valor Equity Partners IV-A L.P. and Valor Equity Partners IV-B L.P.) that are the members of Valor IV Pharma Holdings, LLC. Antonio Gracias and Juan Sabater, each of whom is a director of the Issuer, may each be deemed to share beneficial ownership over the shares of the Issuer held by Valor IV Pharma Holdings, LLC by virtue of their positions with the above Valor entities; however, each disclaims beneficial ownership of the shares held by Valor IV Pharma Holdings, LLC